HTA Harmonization in the EU: Panel Discussion & Roundtable on June 5 at BIO in Boston
?Lance Anderson

HTA Harmonization in the EU: Panel Discussion & Roundtable on June 5 at BIO in Boston

Two very relevant events at the BIO Convention : We will talk about the harmonization of HTA regulations in the European Union, currently the most important topic for the pharmaceutical industry in the EU. On June 5 at 13:00 in room 209 and at 14:30 in room 153. Both events will also give an overview of the EU pharmaceutical landscape and the OMP Regulation.

What does a biopharma company with an asset in late-stage clinical development need to know so that this asset can easily reach patients in the EU? My colleague Fabian Berkemeier discusses with Claire Skentelbery , Director General, EuropaBio and Alexander Natz , Secretary General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs, Steffen Thirstrup , Chief Medical Officer at the European Medicines Agency, Nicholas Cosenza , Senior Manager Government Affairs at Amgen and?Thomas Bols , Head of Government Affairs and Patient Advocacy, EMEA & APAC at PTC Therapeutics, Inc.?Come join us! It is sure to be enlightening! #Bio2023 #IGES #HTA #EUHTA #Reimbursement

要查看或添加评论,请登录

社区洞察

其他会员也浏览了